WinstonWınston
Back
Pediatrix Medical Group logo

Pediatrix Medical Group

MD
59
Medical - Care Facilities · Healthcare
Price
$26.57
+0.35 (+1.33%)
Market Cap
$2.18B
Winston Score
59
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Strong
Cash Flow
Strong
Stability
Strong
Valuation
Strong

Share count falling — buybacks

1.3% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 86.4M (2021) → 85.3M (2025)

Winston Score History

The full picture

Pediatrix Medical Group is a company that provides doctor services inside hospitals, focused on caring for newborns, mothers, and children. Their main services include neonatal care (caring for sick or premature babies in hospital nurseries), maternal-fetal medicine, and pediatric specialty care. They are one of the largest physician practice management companies in the United States focused on women's and children's health.

Pediatrix makes money by billing patients and insurance companies, including government programs like Medicaid and Medicare, for the medical services their doctors provide. The company operates across hundreds of hospitals in the United States, generating roughly $2 billion in annual revenue. Their competitive position comes from their scale — hospitals often prefer to outsource specialty physician staffing to one large, reliable partner rather than manage it themselves. The key risk the business faces is reimbursement pressure, meaning government and private insurers could reduce how much they pay per patient visit, which would directly squeeze the company's margins.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+4.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+11.1% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

1.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$404M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Pediatrix Medical Group is growing revenue at 4% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
27.2%
Modest — 27.2% gross margin
Profit after running costs
Operating Margin
11.7%
Modest — 11.7% operating margin
Return on the money invested
ROCE
15.4%
Strong — 15.4% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+0.5%
Nearly flat sales (+0.5% YoY)
Profit growth
EPS YoY
+66.1%
Earnings growing fast (+66.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
7/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
141%
Turns 141% of profit into real cash
Spare cash per sale
FCF Margin
11.7%
Modest free cash flow (11.7%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.66
Moderate — manageable debt (0.66)
Covers its interest
Interest Cover
8.01x
Comfortably covers interest (8.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
12.6x
Attractive valuation — P/E 12.6

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+1.2
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial